Cor Vasa 2018, 60(1):e9-e17 | DOI: 10.1016/j.crvasa.2017.12.005

Panvascular disease - Diagnosis and management

Katerina K. Nakaa, Victor Aboyansb,c, Charalambos Vlachopoulosd,*
a 2nd Department of Cardiology, University Hospital of Ioannina, University of Ioannina Medical School, Ioannina, Greece
b Inserm 1094, Tropical Neuroepidemiology, Limoges University, Limoges, France
c Department of Cardiology, Dupuytren University Hospital, Limoges, France
d 1st Department of Cardiology, National and Kapodistrian University of Athens, Greece

Panvascular disease (PVD) increases significantly the risk for cardiovascular events (myocardial infarction, stroke and cardiovascular death); the more sites affected, the greater the risk of a major cardiac event. Despite its high incidence and severe cardiovascular prognosis, PVD has still not been well studied. History of risk factors and co-morbidities, as well as a detailed physical examination, are mandatory in the initial screening and diagnostic work-up. The ankle-brachial index and various non-invasive imaging methods such as duplex ultrasound, computed tomography or magnetic resonance angiography are used for the diagnosis of atherosclerosis in various vascular beds, while digital subtraction angiography is currently used almost exclusively in association with endovascular procedures. Appropriate utilization of techniques is based on international guidelines and a multidisciplinary discussion for each case.
Management of a patient diagnosed with PVD can be very complex. Secondary preventive measures and aggressive medical treatment are needed to reduce excess cardiovascular risk. Whether routine screening for atherosclerosis at various sites in the arterial tree in all or selected patients may alter treatment to improve outcome in these patients has not been shown.
In the lack of hard evidence, individualized decision-making is needed with the collaboration of many specialties in a multidisciplinary approach. In general, the more symptomatic lesion or the lesion with the strongest prognostic impact should be treated first. In selected cases combined interventions can be done. Perioperative cardiovascular complications are common in patients with PVD, thus preoperative targeted screening may be needed.
Clinical studies are needed to identify more effective approaches to diagnose and treat these patients. A single trial performed so far failed to demonstrate a panvascular screening in patients with severe coronary artery disease. Meanwhile, a multidisciplinary team is often needed to optimize short- and long-term prognosis.

Keywords: Ankle-brachial index; Carotid artery disease; Computed tomography angiography; Diagnosis; Magnetic resonance angiography; Panvascular disease; Peripheral artery disease; Treatment

Received: November 8, 2017; Accepted: November 15, 2017; Published: February 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Naka KK, Aboyans V, Vlachopoulos C. Panvascular disease - Diagnosis and management. Cor Vasa. 2018;60(1):e9-17. doi: 10.1016/j.crvasa.2017.12.005.
Download citation

References

  1. V. Aboyans, J.B. Ricco, M.E.L. Bartelink, et al., 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and arteries. Endorsed by: the European Stroke Organization (ESO). The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS), European Heart Journal (2017 Aug 26), http://dx.doi.org/10.1093/eurheartj/ehx095. Go to original source... Go to PubMed...
  2. C. Vlachopoulos, D. Terentes-Printzios, C. Stefanadis, How to identify subjects with poly-vascular disease?, Current Vascular Pharmacology 10 (2012) 728-730. Go to original source... Go to PubMed...
  3. A. Gallino, M. Stuber, F. Crea, et al., "In vivo" imaging of atherosclerosis, Atherosclerosis 224 (2012) 25-36. Go to original source... Go to PubMed...
  4. A.T. Hirsch, M.H. Criqui, D. Treat-Jacobson, et al., Peripheral arterial disease detection, awareness, and treatment in primary care, JAMA 286 (2001) 1317-1324. Go to original source... Go to PubMed...
  5. C.E. Clark, R.S. Taylor, A.C. Shore, et al., Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis, Lancet 379 (2012) 905-914. Go to original source... Go to PubMed...
  6. Ankle Brachial Index Collaboration, F.G. Fowkes, G.D. Murray, et al., Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis, JAMA 300 (2008) 197-208. Go to original source... Go to PubMed...
  7. V. Aboyans, M.H. Criqui, P. Abraham, et al., American Heart Association Council on Peripheral Vascular Disease; Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association, Circulation 126 (2012) 2890-2909. Go to original source... Go to PubMed...
  8. Collet on behalf of the Action Group, The America study, in: Presented at the Hotline Session of the European Society of Cardiology Congress, 2017, http://congress365.escardio.org/Presentation/142610?_ga=2.90563603.886713191.1509809152-1382416573.1461490779#.Wf3cVWjWw2w.
  9. W. Wijns, P. Kolh, N. Danchin, et al., Guidelines on myocardial revascularization, European Heart Journal 31 (2010) 2501-2555. Go to original source... Go to PubMed...
  10. M. Tendera, V. Aboyans, M.L. Bartelink, et al., ESC guidelines on the diagnosis and treatment of peripheral artery diseases: document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology, European Heart Journal 32 (2011) 2851-2906. Go to original source...
  11. T.M. Valentijn, R.J. Stolker, Lessons from the REACH Registry in Europe, Current Vascular Pharmacology 10 (2012) 725-727. Go to original source... Go to PubMed...
  12. P.P. Cacoub, D.L. Bhatt, P.G. Steg, et al., Patients with peripheral arterial disease in the CHARISMA trial, European Heart Journal 30 (2009) 192-201. Go to original source...
  13. M.P. Bonaca, D.L. Bhatt, R.F. Storey, et al., Ticagrelor for prevention of ischemic events after myocardial infarction in patients with peripheral artery disease, Journal of the American College of Cardiology 67 (2016) 2719-2728. Go to original source... Go to PubMed...
  14. D.L. Bhatt, E.D. Peterson, R.A. Harrington, et al., Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromes, European Heart Journal 30 (2009) 1195-1202. Go to original source... Go to PubMed...
  15. E.M. Mahoney, K. Wang, D.J. Cohen, et al., One-year costs in patients with a history of or at risk for atherothrombosis in the United States, Circulation: Cardiovascular Quality and Outcomes 1 (2008) 38-45. Go to original source... Go to PubMed...
  16. V. Aboyans, P. Lacroix, Indications for carotid screening in patients with coronary artery disease, Presse Medicale 38 (2009) 977-986. Go to original source... Go to PubMed...
  17. J.C. Lin, L.S. Kabbani, E.L. Peterson, et al., Clinical utility of carotid duplex ultrasound prior to cardiac surgery, Journal of Vascular Surgery 63 (2016) 710-714. Go to original source... Go to PubMed...
  18. A.R. Naylor, Delay may reduce procedural risk, but at what price to the patient?, European Journal of Vascular and Endovascular Surgery 35 (2008) 383-391. Go to original source... Go to PubMed...
  19. A.R. Naylor, R.L. Cuffe, P.M. Rothwell, et al., A systematic review of outcomes following staged and synchronous carotid endarterectomy and coronary artery bypass, European Journal of Vascular and Endovascular Surgery 25 (2003) 380-389. Go to original source... Go to PubMed...
  20. K.I. Paraskevas, S. Nduwayo, A.N. Saratzis, et al., Carotid stenting prior to coronary bypass surgery: an updated systematic review and meta-analysis, European Journal of Vascular and Endovascular Surgery 53 (2017) 309-319. Go to original source... Go to PubMed...
  21. M.H. Shishehbor, S. Venkatachalam, Z. Sun, et al., A direct comparison of early and late outcomes with three approaches to carotid revascularization and open heart surgery, Journal of the American College of Cardiology 62 (2013) 1948-1956. Go to original source... Go to PubMed...
  22. L. Bax, A.J. Woittiez, H.J. Kouwenberg, et al., Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial, Annals of Internal Medicine 150 (2009) 840-848. Go to original source... Go to PubMed...
  23. K. Wheatley, N. Ives, R. Gray, et al., Revascularization versus medical therapy for renal-artery stenosis, New England Journal of Medicine 361 (2009) 1953-1962. Go to original source...
  24. C.J. Cooper, T.P. Murphy, D.E. Cutlip, et al., Stenting and medical therapy for atherosclerotic renal-artery stenosis, New England Journal of Medicine 370 (2014) 13-22. Go to original source... Go to PubMed...
  25. V. Aboyans, I. Desormais, J. Magne, et al., Renal artery stenosis in patients with peripheral artery disease: prevalence, risk factors and long-term prognosis, European Journal of Vascular and Endovascular Surgery 53 (2016) 380-385. Go to original source... Go to PubMed...
  26. A.A. Hussein, K. Uno, K. Wolski, et al., Peripheral arterial disease and progression of coronary atherosclerosis, Journal of the American College of Cardiology 57 (2011) 1220-1225. Go to original source... Go to PubMed...
  27. D. Mukherjee, K.A. Eagle, E. Kline-Rogers, et al., GRACE Investigators. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the global registry of acute coronary events), American Journal of Cardiology 100 (2007) 1-6. Go to original source... Go to PubMed...
  28. S. Subherwal, D.L. Bhatt, S. Li, et al., Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction, Circulation: Cardiovascular Quality and Outcomes 5 (2012) 541-549. Go to original source... Go to PubMed...
  29. V. Aboyans, P. Lacroix, A. Postil, et al., Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting, Journal of the American College of Cardiology 46 (2005) 815-820. Go to original source... Go to PubMed...
  30. S.C. Inglis, J. Bebchuk, S.A. Al-Suhaim, et al., Peripheral artery disease and outcomes after myocardial infarction: an individual-patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT, International Journal of Cardiology 168 (2013) 1094-1101. Go to original source... Go to PubMed...
  31. M.A. Hlatky, D.B. Boothroyd, L. Baker, et al., Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study, Annals of Internal Medicine 158 (2013) 727-734. Go to original source... Go to PubMed...
  32. V. Farooq, D. van Klaveren, E.W. Steyerberg, et al., Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II, Lancet 381 (2013) 639-650. Go to original source... Go to PubMed...
  33. S.M. Grenon, E. Vittinghoff, C.D. Owens, et al., Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study, Vascular Medicine 18 (2013) 176-184. Go to original source... Go to PubMed...
  34. R. Hofmann, A. Kypta, C. Steinwender, et al., Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease, Heart 91 (2005) 1438-1441. Go to original source... Go to PubMed...
  35. D. Calvet, E. Touze, O. Varenne, et al., Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: the PRECORIS study, Circulation 121 (2010) 1623-1629. Go to original source... Go to PubMed...
  36. G. Illuminati, J.B. Ricco, C. Greco, et al., Systematic preoperative coronary angiography and stenting improve postoperative results of carotid endarterectomy in patients with asymptomatic coronary artery disease: a randomised controlled trial, European Journal of Vascular and Endovascular Surgery 39 (2010) 139-145. Go to original source... Go to PubMed...
  37. G. Illuminati, F. Schneider, C. Greco, et al., Long-term results of a randomized controlled trial analyzing the role of systematic pre-operative coronary angiography before elective carotid endarterectomy in patients with asymptomatic coronary artery disease, European Journal of Vascular and Endovascular Surgery 49 (2015) 366-374. Go to original source... Go to PubMed...
  38. I. Cho, H. Chang, J.M. Sung, et al., Coronary computed tomographic angiography and risk of all-cause mortality and nonfatal myocardial infarction in subjects without chest pain syndrome from the CONFIRM Registry (coronary CT angiography evaluation for clinical outcomes: an international multicenter registry), Circulation 126 (2012) 304-313. Go to original source... Go to PubMed...
  39. W.E. Boden, R.A. O'Rourke, K.K. Teo, et al., COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease, New England Journal of Medicine 356 (2007) 1503-1516. Go to original source... Go to PubMed...
  40. P.G. Steg, D.L. Bhatt, P.W. Wilson, et al., For the REACH Registry Investigators. One-year cardiovascular event rates in outpatients with atherothrombosis, JAMA 297 (2007) 1197-1206. Go to original source... Go to PubMed...
  41. D.L. Bhatt, K.A. Eagle, E.M. Ohman, et al., REACH Registry Investigators. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis, JAMA 304 (2010) 1350-1357. Go to original source... Go to PubMed...
  42. G. Montalescot, U. Sechtem, S. Achenbach, et al., 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology, European Heart Journal 34 (2013) 2949-3003. Go to original source...
  43. S.D. Kristensen, J. Knuuti, A. Saraste, et al., 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA), European Journal of Anaesthesiology 31 (2014) 517-573. Go to original source... Go to PubMed...




Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.